Aplenzin XR Shortage Update: What Patients Need to Know in 2026

Is Aplenzin XR in Shortage in 2026?

If you're struggling to find Aplenzin XR at your pharmacy, you're probably wondering: is there an actual shortage? The answer is nuanced — and understanding it can help you get your prescription filled faster.

As of March 2026, Aplenzin (Bupropion Hydrobromide) is not officially listed on the FDA's drug shortage database. But that doesn't mean it's easy to find. Aplenzin is a brand-only medication manufactured by a single company (Bausch Health), and many pharmacies across the country simply don't stock it. The result feels like a shortage even if the supply chain says otherwise.

Is Aplenzin XR Still Hard to Find?

Yes. Patients across the U.S. continue to report difficulty finding Aplenzin XR at local pharmacies in 2026. Here's why the situation persists:

• Single-source manufacturing: Only Bausch Health makes Aplenzin. There are no generic Bupropion Hydrobromide products on the market yet.
• Low pharmacy stocking rates: With a cash price exceeding $3,200 per month, most pharmacies don't keep Aplenzin on their shelves unless they have regular customers filling it.
• Insurance steers patients to generics: Most insurers prefer (or require) generic Bupropion HCl, which keeps Aplenzin prescription volumes low at any given pharmacy.

For a deeper dive into the supply dynamics, read our post on why Aplenzin XR is so hard to find in 2026.

Why Is Aplenzin XR Hard to Find?

Understanding the root causes helps you plan better.

The Generic Bupropion Market Matters

The broader Bupropion market has been rocky. Generic Bupropion HCl extended-release products experienced significant shortages in 2023 and 2024 due to manufacturing disruptions and surging demand. While the generic supply has improved, some patients who struggled during those shortages moved to Aplenzin — putting pressure on an already limited supply.

No Generic Aplenzin Yet

Although generic Bupropion HCl (Wellbutrin XL equivalent) has been available for years, no generic version of Aplenzin (Bupropion Hydrobromide) has been approved. Patent protections have kept competitors out. The earliest estimated date for generic entry is mid-2026, which could eventually improve availability and bring prices down — but that relief hasn't arrived yet.

Supply Chain Vulnerability

When you have a single manufacturer serving the entire market for a medication, any disruption — a production delay, a raw material shortage, a distribution hiccup — can ripple across the country. Brand-only drugs like Aplenzin are inherently more vulnerable to these issues.

What Does Aplenzin XR Cost in 2026?

Cost is a major factor in the Aplenzin story. Here's what patients are facing:

• Cash price (without insurance): Approximately $3,200-$3,555 per month for a 30-day supply of 348 mg tablets
• With commercial insurance: Copays vary widely; Aplenzin is typically on a non-preferred brand tier (Tier 3+), which can mean $50-$200+ per month
• With the Bausch Health copay card: Eligible commercially insured patients may pay significantly less — visit aplenzin.com/savings-access
• Generic Bupropion HCl XL (alternative): $15-$40 per month

For detailed strategies on reducing your costs, see how to save money on Aplenzin XR in 2026.

Are There New Options for Patients in 2026?

A few developments may help Aplenzin patients this year:

Potential Generic Entry in Mid-2026

Patent analysis suggests the earliest date for a generic Bupropion Hydrobromide product could be June 2026. If a generic launches, it could dramatically lower costs and increase availability. We'll update this post as new information becomes available.

Manufacturer Programs

Bausch Health continues to offer the Aplenzin Savings & Access Program, which includes copay savings for commercially insured patients and may provide free delivery. The Bausch Health Patient Assistance Program (bauschhealthpap.com) offers free medication to qualifying uninsured or underinsured patients.

Telehealth Access

If you need a new prescription or need to discuss alternatives, telehealth psychiatry and primary care appointments can save you time. Many telehealth providers can prescribe Aplenzin or help you switch formulations. See our guide on finding a doctor who can prescribe Aplenzin XR.

How to Find Aplenzin XR in Stock Right Now

Here's your action plan:

1. Search Medfinder to find pharmacies near you with Aplenzin in stock
2. Call independent pharmacies — they're more likely to stock or quickly order brand medications
3. Ask your pharmacy to order it — many can get it in 1-2 business days from their wholesaler
4. Enroll in the manufacturer's access program for potential direct delivery
5. Talk to your doctor about generic Bupropion HCl XL as a bridge if you're running out

For a complete strategy guide, read how to find Aplenzin XR in stock near you.

Final Thoughts

The Aplenzin XR situation in 2026 is a combination of limited supply, high cost, and systemic insurance barriers — not a traditional manufacturing shortage. But for patients who rely on this medication, the distinction doesn't matter much when your pharmacy says "we don't have it."

Stay proactive: use Medfinder to track availability, keep your prescriber informed, explore savings programs, and know your alternatives. The landscape may improve later in 2026 if generic options arrive, but for now, preparation is your best tool.

For a comprehensive look at what to expect from this medication, visit our guide on what Aplenzin XR is, its uses, and what you need to know.